Eversept Partners, LP

SEC CIK: 0001697013
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Eversept Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overview All 13F holders of RARE Full Q2 2026 holdings

Shares (Q2 2026): 154,130
Value: $5.15M
% of portfolio: 0.3%
Quarters held: 3; Since Q4 2025

Holdings of RARE by Eversept Partners, LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	154,130	$5.15M	0.3%	+91,555+146.3%	Added	Holders
Q1 2026	62,575	$1.31M	0.1%	−254,607−80.3%	Reduced	Holders
Q4 2025	317,182	$7.30M	0.4%	+317,182	New	Holders